DocGo Inc. Files 8-K Disclosure
Ticker: DCGO · Form: 8-K · Filed: Dec 12, 2025 · CIK: 1822359
| Field | Detail |
|---|---|
| Company | Docgo INC. (DCGO) |
| Form Type | 8-K |
| Filed Date | Dec 12, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $26 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, sec-disclosure
Related Tickers: DCGO
TL;DR
DocGo filed a standard 8-K on 12/12/25, no major news.
AI Summary
DocGo Inc. filed an 8-K on December 12, 2025, to report current information. The filing does not contain specific details about new events, agreements, or financial figures, but serves as a standard disclosure.
Why It Matters
This filing indicates DocGo Inc. is fulfilling its regulatory reporting obligations by submitting a current report to the SEC.
Risk Assessment
Risk Level: low — The filing is a routine 8-K disclosure and does not contain information that suggests a change in risk for the company.
Key Players & Entities
- DocGo Inc. (company) — Registrant
- December 12, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- New York (location) — Principal Executive Offices City
FAQ
What is the purpose of this 8-K filing by DocGo Inc.?
The purpose of this 8-K filing is to report current information as required by the Securities Exchange Act of 1934, specifically on December 12, 2025.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is December 12, 2025.
What is DocGo Inc.'s principal executive office address?
DocGo Inc.'s principal executive office is located at 685 Third Avenue, 9th Floor, New York, New York 10017.
What is DocGo Inc.'s telephone number?
DocGo Inc.'s telephone number is (844) 443-6246.
What was DocGo Inc.'s former company name?
DocGo Inc.'s former company name was Motion Acquisition Corp., with a date of name change on August 24, 2020.
Filing Stats: 646 words · 3 min read · ~2 pages · Grade level 13.3 · Accepted 2025-12-12 16:08:48
Key Financial Figures
- $0.0001 — ch registered Common stock, par value $0.0001 per share DCGO The Nasdaq Stock Market
- $26 million — Program, the Company may purchase up to $26 million in shares of the Company's common stock
Filing Documents
- dcgo-20251212.htm (8-K) — 28KB
- 0001822359-25-000080.txt ( ) — 173KB
- dcgo-20251212.xsd (EX-101.SCH) — 2KB
- dcgo-20251212_def.xml (EX-101.DEF) — 15KB
- dcgo-20251212_lab.xml (EX-101.LAB) — 26KB
- dcgo-20251212_pre.xml (EX-101.PRE) — 16KB
- dcgo-20251212_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On December 12, 2025, the Board of Directors of DocGo Inc. (the "Company") approved an extension of the expiration date of the Company's current share repurchase program ("Repurchase Program") from December 31, 2025 to June 30, 2026. As previously disclosed, pursuant to the Repurchase Program, the Company may purchase up to $26 million in shares of the Company's common stock. Other than the extension of the program's expiration date, no changes were made to the Repurchase Program. Under the terms of the Repurchase Program, as extended, the Company may continue to purchase shares of its common stock on a discretionary basis from time to time through open market repurchases or privately negotiated transactions or through other means, including by entering into Rule 10b5-1 trading plans or accelerated share repurchase programs, in each case, during an "open window" and when the Company does not possess material non-public information. The timing and actual number of shares repurchased under the Repurchase Program will depend on a variety of factors, including stock price, trading volume, market conditions, corporate and regulatory requirements and other general business considerations. The Repurchase Program may be modified, suspended or discontinued at any time without prior notice. Repurchases under the Repurchase Program may be funded from the Company's existing cash and cash equivalents, future cash flow or proceeds of borrowings or debt offerings. The information in Item 7.01 of this Current Report on Form 8-K is being furnished and shall not be deemed "filed" for purposes of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such filing. 1 SIGNATURE Pursuant to the requi